Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Jun / Educational E-book: Advances in Oncology
Oncology Oncology Precision medicine Profession Screening and monitoring

Educational e-book: Advances in Oncology

An overview of the latest laboratory considerations in cancer research, diagnosis, and treatment

06/28/2022 Review 2 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Report: Educational e-book: Advances in Oncology

Overview

The e-book compiles recent advancements in oncology, focusing on cervical cancer screening, liquid biopsy applications, and the importance of patient advocacy. It highlights the need for improved screening adherence and the integration of molecular diagnostics in treatment planning.

Background

Cervical cancer remains a significant public health concern, necessitating updated screening guidelines and innovative diagnostic methods. The shift toward primary HPV testing and self-collection reflects a growing recognition of the need for accessible screening options. Additionally, advancements in molecular oncology, such as assessing microsatellite instability, are crucial for personalizing cancer treatment and improving patient outcomes.

Data Highlights

No numerical data provided in the source material.

Key Findings

Rephrase findings for clarity and ensure they are directly supported by the e-book.

Clinical Implications

Healthcare professionals should prioritize adherence to updated cervical cancer screening guidelines, including the use of self-collection methods. Additionally, integrating molecular diagnostics into clinical practice can enhance treatment personalization and improve patient outcomes.

Conclusion

The e-book serves as a valuable resource for oncology professionals, emphasizing the importance of updated screening practices and the integration of patient perspectives in cancer care.

Related Resources & Content

  1. American Cancer Society, New Cervical Cancer Screening Guideline Aims to Reduce Deaths, 2025 -- New Cervical Cancer Screening Guideline Aims to Reduce Deaths
  2. The ASCO Post, 2019 ASCO Educational Book Explores Practice-Changing Cancer Research, 2019 -- 2019 ASCO Educational Book Explores Practice-Changing Cancer Research
  3. College of American Pathologists, Mismatch Repair and Microsatellite… -- Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy
  4. The ASCO Post — 100 Years of Progress in Oncology Treatment Related Articles
  5. Frontiers in Oncology — Editorial: Advancements in Personalized Medicine for Head and Neck Cancer: Molecular-based Approaches to Treatment and Care
  6. the asco post — Bridging the Gap in Geriatric Oncology Education: A Global Imperative
  7. New Cervical Cancer Screening Guideline Aims to Reduce Deaths | American Cancer Society
  8. Mismatch Repair and Microsatellite… | College of American Pathologists
  9. Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | New England Journal of Medicine
  10. CIRCULATE-Japan GALAXY Confirms Effectiveness of Liquid Biopsy in Predicting Recurrence Risk and Post-operative Treatment Efficacy in Colorectal Cancer -Published in Nature Medicine- | National Cancer Center Japan
  11. The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease | Journal of Clinical Oncology
  12. Updates in Glioma and Meningioma… | College of American Pathologists
  13. LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA - PMC
  14. Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis | Journal of Neuro-Oncology | Springer Nature Link
  15. FDA grants accelerated approval to dordaviprone for diffuse midline glioma | FDA

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.